These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 10370890)

  • 1. [Anticonvulsants in agitation and behavior disorders in demented subjects. Report of 8 cases].
    Fahs H; Potiron G; Senon JL; Perivier E
    Encephale; 1999; 25(2):169-74. PubMed ID: 10370890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Case report of sodium valproate treatment of aggression associated with Alzheimer's disease].
    Takahashi M; Akagi M
    No To Shinkei; 1996 Aug; 48(8):757-60. PubMed ID: 8797211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of carbamazepine on agitation in Alzheimer's inpatients refractory to neuroleptics.
    Lemke MR
    J Clin Psychiatry; 1995 Aug; 56(8):354-7. PubMed ID: 7635851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
    De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A
    Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Report on an open-label prospective study of divalproex sodium for the behavioral and psychological symptoms of dementia as monotherapy and in combination with second-generation antipsychotic medication.
    Forester B; Vanelli M; Hyde J; Perez R; Ahokpossi C; Sribney W; Adkison L
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):209-17. PubMed ID: 17996660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of anticonvulsants in treating agitated demented elderly patients.
    Grossman F
    Pharmacotherapy; 1998; 18(3):600-6. PubMed ID: 9620110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agitation as a possible expression of generalized anxiety disorder in demented elderly patients: toward a treatment approach.
    Mintzer JE; Brawman-Mintzer O
    J Clin Psychiatry; 1996; 57 Suppl 7():55-63; discussion 73-5. PubMed ID: 8690698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose propranolol reduces aggression and agitation resembling that associated with orbitofrontal dysfunction in elderly demented patients.
    Shankle WR; Nielson KA; Cotman CW
    Alzheimer Dis Assoc Disord; 1995; 9(4):233-7. PubMed ID: 8749613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of oxcarbazepine in the treatment of agitation and aggression in severe dementia.
    Sommer OH; Aga O; Cvancarova M; Olsen IC; Selbaek G; Engedal K
    Dement Geriatr Cogn Disord; 2009; 27(2):155-63. PubMed ID: 19182483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of agitation and aggression associated with Alzheimer's disease: controversies and possible solutions.
    Ballard C; Corbett A; Chitramohan R; Aarsland D
    Curr Opin Psychiatry; 2009 Nov; 22(6):532-40. PubMed ID: 19696673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbamazepine treatment of agitation in Alzheimer's outpatients refractory to neuroleptics.
    Gleason RP; Schneider LS
    J Clin Psychiatry; 1990 Mar; 51(3):115-8. PubMed ID: 1968457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zolpidem for the treatment of agitation in elderly demented patients.
    Jackson CW; Pitner JK; Mintzer JE
    J Clin Psychiatry; 1996 Aug; 57(8):372-3. PubMed ID: 8752023
    [No Abstract]   [Full Text] [Related]  

  • 13. Neuroleptics and alternative treatments. Management of behavioral symptoms and psychosis in Alzheimer's disease and related conditions.
    Wragg RE; Jeste DV
    Psychiatr Clin North Am; 1988 Mar; 11(1):195-213. PubMed ID: 2898133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral complications and their treatment in Alzheimer's disease.
    Devanand DP
    Geriatrics; 1997 Sep; 52 Suppl 2():S37-9. PubMed ID: 9307585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A placebo-controlled trial of valproate for agitation and aggression in Alzheimer's disease.
    Herrmann N; Lanctôt KL; Rothenburg LS; Eryavec G
    Dement Geriatr Cogn Disord; 2007; 23(2):116-9. PubMed ID: 17148938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical neuroleptics as a treatment of agitation and anxiety in Alzheimer's disease: risks or benefits.
    Moretti R; Torre P; Antonello RM; Pizzolato G
    Expert Rev Neurother; 2006 May; 6(5):705-10. PubMed ID: 16734518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amisulpride in the treatment of behavioural disturbances among patients with moderate to severe Alzheimer's disease.
    Mauri M; Mancioli A; Rebecchi V; Corbetta S; Colombo C; Bono G
    Acta Neurol Scand; 2006 Aug; 114(2):97-101. PubMed ID: 16867031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allelic variation at the A218C tryptophan hydroxylase polymorphism influences agitation and aggression in Alzheimer's disease.
    Craig D; Hart DJ; Carson R; McIlroy SP; Passmore AP
    Neurosci Lett; 2004 Jun; 363(3):199-202. PubMed ID: 15182943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Agitation expressing pain in demented people with communication disorders].
    Pradines V; Pradines B
    Psychol Neuropsychiatr Vieil; 2004 Dec; 2(4):271-4. PubMed ID: 15683982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapeutic use of carbamazepine for treatment of agitation and affective disorders in geriatric psychiatry patients].
    Lemke MR; Stuhlmann W
    Psychiatr Prax; 1994 Jul; 21(4):147-50. PubMed ID: 7938323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.